Patent Document ID: 9909185
Application ID: 13656568
Patent Flag: 1

Claim One:
1. A method of classifying and treating an individual having breast cancer, comprising: obtaining a sample comprising tumor cells from the individual; extracting polynucleotide molecules from said sample; synthesizing complementary RNA (cRNA) or complementary DNA (cDNA) nucleic acid molecules from the extracted polynucleotide molecules; exposing the cRNA or cDNA nucleic acid molecules from a breast cancer tumor of the individual to probes in the range of 20-200 nucleotides that specifically hybridize to a nucleic acid molecule having SEQ ID NO:1844; comparing the hybridization of the probe to the nucleic acid molecule having SEQ ID NO:1844 with the hybridization of the probe to the nucleic acid molecule having SEQ ID NO:1844 in a standard or control, wherein the standard or control comprises complementary RNA (cRNA) or cDNA nucleic acid molecules from a breast sample from an individual afflicted with a good prognosis breast cancer, wherein a decrease in probe hybridization, when compared with the standard or control, is indicative of a poor prognosis; classifying the individual as having a poor prognosis; and administering chemotherapy to the individual classified as having a poor prognosis.